Pharmaceutical Technology25d
Allink Biotherapeutics secures funding to advance ADC pipeline
Allink Biotherapeutics has completed a $42m Series A financing round to expedite the worldwide development of its bispecific ...
Yahoo Finance26d
Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. "Since our company's inception a ...
Yahoo Finance25d
Allink Biotherapeutics secures funding to advance ADC pipeline
Allink Biotherapeutics has completed a $42m Series A financing round to expedite the worldwide development of its bispecific antibody and antibody-drug conjugate (ADC) pipeline. The funding will ...
Morningstar26d
Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. "Since company inception a little over ...
Mena FN26d
Allink Biotherapeutics Raises $42M Series A Financing To Accelerate Global Development Of Bispecific Antibody And ADC Pipeline
SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics ...
Taiwan News25d
Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. "Since our company's inception a little ...
Mena FN26d
Lanchi Ventures Leads $42M Series A Financing For Allink Biotherapeutics To Accelerate Global Development Of Bispecific Antibody And ADC Pipeline
BEIJING, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics ...
Taiwan News25d
Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
BEIJING, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics, ...